Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

OmniLit Acquisition (OLIT) Competitors

OmniLit Acquisition logo

OLIT vs. PRE, OMIC, OPXS, AATC, MSAI, AXDX, DAIO, ASTC, PRPO, and TLIS

Should you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include Prenetics Global (PRE), Singular Genomics Systems (OMIC), Optex Systems (OPXS), Autoscope Technologies (AATC), MultiSensor AI (MSAI), Accelerate Diagnostics (AXDX), Data I/O (DAIO), Astrotech (ASTC), Precipio (PRPO), and Talis Biomedical (TLIS). These companies are all part of the "measuring and control equipment" industry.

OmniLit Acquisition vs.

Prenetics Global (NASDAQ:PRE) and OmniLit Acquisition (NASDAQ:OLIT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings, community ranking and profitability.

OmniLit Acquisition has a net margin of 0.00% compared to Prenetics Global's net margin of -191.73%. OmniLit Acquisition's return on equity of 0.00% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-191.73% -16.45% -13.34%
OmniLit Acquisition N/A N/A N/A

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 21.6% of OmniLit Acquisition shares are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 78.0% of OmniLit Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Prenetics Global has a beta of -0.3, meaning that its share price is 130% less volatile than the S&P 500. Comparatively, OmniLit Acquisition has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500.

Prenetics Global received 7 more outperform votes than OmniLit Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Prenetics GlobalOutperform Votes
7
87.50%
Underperform Votes
1
12.50%
OmniLit AcquisitionN/AN/A

Prenetics Global currently has a consensus price target of $9.00, indicating a potential upside of 66.36%. Given Prenetics Global's stronger consensus rating and higher probable upside, research analysts plainly believe Prenetics Global is more favorable than OmniLit Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
OmniLit Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

OmniLit Acquisition has lower revenue, but higher earnings than Prenetics Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$21.74MN/A-$62.72M-$3.99-1.36
OmniLit AcquisitionN/AN/AN/AN/AN/A

In the previous week, Prenetics Global had 2 more articles in the media than OmniLit Acquisition. MarketBeat recorded 2 mentions for Prenetics Global and 0 mentions for OmniLit Acquisition. Prenetics Global's average media sentiment score of 1.42 beat OmniLit Acquisition's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company Overall Sentiment
Prenetics Global Positive
OmniLit Acquisition Neutral

Summary

Prenetics Global beats OmniLit Acquisition on 8 of the 13 factors compared between the two stocks.

Get OmniLit Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OLIT vs. The Competition

MetricOmniLit AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$13.14M$469.41M$124.73M$9.12B
Dividend YieldN/A7.20%5.15%3.98%
P/E RatioN/A2.501.1717.51
Price / SalesN/A141.551.0383.27
Price / CashN/A66.5389.1837.67
Price / BookN/A4.891.014.72
Net IncomeN/A$34.48M$1.73M$224.62M

OmniLit Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OLIT
OmniLit Acquisition
N/A$2.14
-7.8%
N/AN/A$13.14MN/A0.003Gap Down
High Trading Volume
PRE
Prenetics Global
2.8858 of 5 stars
$5.45
+2.8%
$9.00
+65.1%
+16.0%$52.31M$21.74M-1.371Positive News
Gap Down
OMIC
Singular Genomics Systems
1.8833 of 5 stars
$19.85
+0.5%
$10.75
-45.8%
+32.0%$50.41M$2.91M-0.57220
OPXS
Optex Systems
2.8795 of 5 stars
$6.78
-0.2%
N/A+26.6%$46.75M$33.99M12.3280Short Interest ↓
AATC
Autoscope Technologies
N/A$8.03
-2.3%
N/A-12.6%$44.00M$13.13M9.1340Ex-Dividend
MSAI
MultiSensor AI
3.5261 of 5 stars
$1.44
-4.6%
$8.00
+455.6%
-35.9%$43.68M$5.43M0.0035Positive News
Gap Up
AXDX
Accelerate Diagnostics
3.8753 of 5 stars
$1.33
+7.3%
$1.00
-24.8%
-3.0%$33.30M$12.06M-0.47220Analyst Forecast
Short Interest ↓
News Coverage
Positive News
Gap Up
DAIO
Data I/O
2.5706 of 5 stars
$2.89
-2.5%
$4.00
+38.6%
-12.0%$26.66M$28.06M-15.18100Short Interest ↓
News Coverage
Gap Up
ASTC
Astrotech
0.5616 of 5 stars
$6.90
+2.2%
N/A-12.7%$11.73M$1.66M-0.9410Short Interest ↓
PRPO
Precipio
1.2692 of 5 stars
$6.47
-0.5%
N/A+4.4%$9.58M$15.20M-3.5460Short Interest ↓
Positive News
Gap Down
TLIS
Talis Biomedical
N/A$1.57
flat
N/A-80.5%$2.86M$2.13M-0.06260

Related Companies and Tools


This page (NASDAQ:OLIT) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners